References

Evaluation of an oral small-molecule glucagon-like peptide-1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: a dose-ranging, phase 2, randomized, placebo-controlled study

10.1111/dom.16005 · 2025 · External reference

Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists

10.1007/s12325-021-01710-0 · 2021 · External reference

Curbing the appetites and restoring the capacity for satisfaction: the impact of GLP-1 agonists on the reward circuitry

10.1016/j.nsa.2025.105512 · 2025 · External reference

Glucagon-like Peptide-1 and hypothalamic regulation of satiation: cognitive and neural insights from human and animal studies

10.4093/dmj.2025.0106 · 2025 · External reference

What is food noise? A conceptual model of food cue reactivity

10.3390/nu15224809 · 2023 · External reference

Calorie restriction influences key metabolic enzyme activities and markers of oxidative damage in distinct mouse liver mitochondrial sub-populations

10.1016/j.lfs.2013.10.006 · 2013 · External reference

Alterations of ultrastructural and fission/fusion markers in hepatocyte mitochondria from mice following calorie restriction with different dietary fats

10.1093/gerona/glt006 · 2013 · External reference

Sex-specific mitochondrial dysregulation and metformin response in Wilson disease

10.1038/s41598-026-58720-7 · 2026 · External reference

Maternal plasma metabolic profile demarcates a role for neuroinflammation in non-typical development of children

10.3390/metabo11080545 · 2021 · External reference

Brain atrophy and white matter damage linked to peripheral bioenergetic deficits in the neurodegenerative disease FXTAS

10.3390/ijms22179171 · 2021 · External reference

Is mitochondrial dysfunction a common root of noncommunicable chronic diseases?

10.1210/endrev/bnaa005 · 2020 · External reference

Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes

10.18388/abp.2017_1634 · 2017 · External reference

Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia

10.1172/jci.insight.134221 · 2020 · External reference

Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells

10.1111/jnc.13736 · 2016 · External reference

Role of Exendin-4 in brain insulin resistance, mitochondrial function, and neurite outgrowth in neurons under palmitic acid-induced oxidative stress

2021 · External reference

Unresolved reference

2022 · External reference

Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

10.1016/j.redox.2023.102849 · 2023 · External reference

Incretin mimetics restore the ER-Mitochondrial axis and switch cell fate towards survival in LUHMES dopaminergic-like neurons: implications for novel therapeutic strategies in Parkinson's disease

10.3233/jpd-230030 · 2023 · External reference

Exendin-4 protects against high glucose-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y neuroblastoma cells through GLP-1 receptor/Epac/Akt signaling

10.1016/j.ejphar.2023.175896 · 2023 · External reference

Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy

10.1016/j.ejphar.2019.172715 · 2019 · External reference

Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy

10.1016/j.mce.2022.111560 · 2022 · External reference

Liraglutide demonstrates a therapeutic effect on mitochondrial dysfunction in human SGBS adipocytes in vitro

10.1016/j.diabres.2023.110635 · 2023 · External reference

The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes

10.1016/j.intimp.2019.105732 · 2019 · External reference

The impact of glucagon and exenatide on oxidative stress levels and antioxidative enzyme expression in in vitro induced steatosis in HepG2 cell culture

10.5603/ep.99891 · 2024 · External reference

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease

10.1016/j.neuropharm.2019.107813 · 2020 · External reference

Incretin-Based multi-agonist peptides are neuroprotective and anti-inflammatory in cellular models of neurodegeneration

10.3390/biom14070872 · 2024 · External reference

Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells

10.1016/j.neuro.2022.08.007 · 2022 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

10.1136/bmj.n71 · 2021 · External reference

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

2021 · External reference

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

2020 · External reference

SYRCLE's risk of bias tool for animal studies

10.1186/1471-2288-14-43 · 2014 · External reference

Systematic review and evidence integration for literature-based environmental health science assessments

10.1289/ehp.1307972 · 2014 · External reference

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

10.1016/j.jclinepi.2010.04.026 · 2011 · External reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

10.1136/bmj.39489.470347.ad · 2008 · External reference

GRADE: assessing the quality of evidence in environmental and occupational health

10.1016/j.envint.2016.01.004 · 2016 · External reference

Mechanisms of action and therapeutic application of glucagon-like Peptide-1

10.1016/j.cmet.2018.03.001 · 2018 · External reference

Glucagon-like peptide 1 (GLP-1)

10.1016/j.molmet.2019.09.010 · 2019 · External reference

Assessing mitochondrial dysfunction in cells

10.1042/bj20110162 · 2011 · External reference